0001477932-14-003877.txt : 20140725 0001477932-14-003877.hdr.sgml : 20140725 20140725060836 ACCESSION NUMBER: 0001477932-14-003877 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140722 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20140725 DATE AS OF CHANGE: 20140725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bio-Solutions Corp. CENTRAL INDEX KEY: 0001420108 STANDARD INDUSTRIAL CLASSIFICATION: GRAIN MILL PRODUCTS [2040] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-147917 FILM NUMBER: 14992593 BUSINESS ADDRESS: STREET 1: 14517, JOSEPH MARC VERMETTE CITY: MIRABEL STATE: A8 ZIP: J7J 1X2 BUSINESS PHONE: 888-686-2611 MAIL ADDRESS: STREET 1: 14517, JOSEPH MARC VERMETTE CITY: MIRABEL STATE: A8 ZIP: J7J 1X2 8-K 1 bisu_8k.htm FORM 8-K bisu_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

July 22, 2014
Date of Report (Date of earliest event reported)
 
BIO-SOLUTIONS CORP.
(Exact name of registrant as specified in its charter)
 
Nevada
  
333-147917
  
98-0557171
(State or Other Jurisdiction
  
(Commission
  
(I.R.S. Employer
of Incorporation or Organization)
  
File Number)
  
Identification No.)
 
10730 Potranco Road, Suite 122 - 686, San Antonio, TX 78251
(Address of Principal Executive Offices) (Zip Code)
 
(210) 268-9409
(Registrant’s telephone number, including area code)
 
N/A
 (Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
 
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

On July 22, 2014, Thomas Metzger PhD, Chief Executive Officer, Chief Financial Officer, President and Chief Operating Officer resigned from the Company. Mr. Metzger’s resignation letter is attached as Exhibit 17.1. In addition, James Hodge, Chairman of the Board of Directors was appointed interim Chief Executive Officer and Chief Financial Officer.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
 
17.1 Letter of Resignation as of July 22, 2014, Thomas Metzger PhD.
 
 
2
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1933, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BIO-SOLUTIONS CORP.
  
       
DATE: July 25, 2014
 By:
/s/ James Hodge
  
   
Chairman of the Board of Directors
  
 
 
3
 EX-17.1 2 bisu_ex171.htm LETTER OF RESIGNATION bisu_ex171.htm
EXHIBIT 17.1
 
James Hodge
Chairman of the Board of Directors
Bio-Solutions Corp.

Jim,

Please accept my resignation as Chief Executive Officer, Chief Financial Officer, President and Chief Operating Officer of Bio-Solutions Corp. I have decided to pursue other interests. I do absolutely support Bio-Solutions Corp. and believe the Type2Defense product will help many people prevent the onslaught of Type 2 Diabetes.
 
With Respect,
 
/s/ Thomas E. Metzger, PhD
Thomas E. Metzger, PhD
July 22, 2014